Here are the latest quarterly results of NURECA. For more details, see the NURECA financial fact sheet and NURECA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
3
Jun-24* |
3
Sep-24* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 278 | 212 | 212 | 314 | 224 | 170 | 203 | 312 | |
Other income | Rs m | 19 | 21 | 27 | 32 | 59 | -13 | 58 | 32 | |
Turnover | Rs m | 297 | 234 | 239 | 346 | 283 | 157 | 261 | 344 | |
Expenses | Rs m | 287 | 247 | 241 | 300 | 266 | 214 | 226 | 335 | |
Gross profit | Rs m | -9 | -35 | -29 | 14 | -43 | -44 | -24 | -24 | |
Depreciation | Rs m | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 6 | |
Interest | Rs m | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | |
Profit before tax | Rs m | 3 | -20 | -9 | 39 | 9 | -65 | 26 | -1 | |
Tax | Rs m | -0 | -4 | -2 | 10 | 8 | -23 | 10 | 4 | |
Profit after tax | Rs m | 3 | -15 | -7 | 29 | 2 | -41 | 17 | -5 | |
Gross profit margin | % | -3.3 | -16.3 | -13.7 | 4.4 | -19.0 | -26.1 | -11.7 | -7.6 | |
Effective tax rate | % | -11.5 | 22.5 | 23.9 | 26.0 | 82.5 | 35.9 | 36.5 | -542.7 | |
Net profit margin | % | 1.1 | -7.2 | -3.3 | 9.2 | 0.7 | -24.4 | 8.2 | -1.5 | |
Diluted EPS | Rs | 0.3 | -1.5 | -0.7 | 2.9 | 0.2 | -4.1 | 1.7 | -0.5 | |
Diluted EPS (TTM) | Rs | -8.1 | -8.2 | -4.8 | 1.0 | 0.8 | -1.8 | 0.6 | -2.8 | |
Subscriber Feature |
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.